FR2333243A2 - Methode de preparation d'une solution d'anticorps - Google Patents

Methode de preparation d'une solution d'anticorps

Info

Publication number
FR2333243A2
FR2333243A2 FR7625159A FR7625159A FR2333243A2 FR 2333243 A2 FR2333243 A2 FR 2333243A2 FR 7625159 A FR7625159 A FR 7625159A FR 7625159 A FR7625159 A FR 7625159A FR 2333243 A2 FR2333243 A2 FR 2333243A2
Authority
FR
France
Prior art keywords
antibody
antigen
strip
dipping
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7625159A
Other languages
English (en)
Other versions
FR2333243B2 (fr
Inventor
Ivar Giaever
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Electric Co
Original Assignee
General Electric Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/608,329 external-priority patent/US4172827A/en
Application filed by General Electric Co filed Critical General Electric Co
Publication of FR2333243A2 publication Critical patent/FR2333243A2/fr
Application granted granted Critical
Publication of FR2333243B2 publication Critical patent/FR2333243B2/fr
Granted legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553Metal or metal coated

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7625159A 1972-06-26 1976-08-19 Methode de preparation d'une solution d'anticorps Granted FR2333243A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26627872A 1972-06-26 1972-06-26
US05/608,329 US4172827A (en) 1972-06-26 1975-08-27 Method for concentration and purification of antigens and antibodies

Publications (2)

Publication Number Publication Date
FR2333243A2 true FR2333243A2 (fr) 1977-06-24
FR2333243B2 FR2333243B2 (fr) 1979-09-07

Family

ID=26951737

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7625159A Granted FR2333243A2 (fr) 1972-06-26 1976-08-19 Methode de preparation d'une solution d'anticorps

Country Status (1)

Country Link
FR (1) FR2333243A2 (fr)

Also Published As

Publication number Publication date
FR2333243B2 (fr) 1979-09-07

Similar Documents

Publication Publication Date Title
ES557705A0 (es) Dispositivo para determinacion de una substancia presente en una muestra
IL58054A (en) Immonological determination of an immuno-complex and diagnostic agent therefor
SE8007396L (sv) Forfarande ocm medel for bestemning av en ligand i ett vetskemedium
US20010005585A1 (en) Enzyme-labeled immunoassay and device therefor
SE8105827L (sv) Immunoanalysprodukter och -metoder
SE8200978L (sv) Forfarande och medel for immunologisk analys
AU498364B2 (en) Assaying antibody, antigen or antibody-antigen complex in fluid sample
SE7413484L (fr)
SE8102558L (sv) Immunologisk bestemmningsmetod
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
GB1485729A (en) Apparatus for determining immunoassays of antigens and their antibodies
ES444543A1 (es) Metodo de determinacion inmunologica.
DE3280319D1 (de) Fuer endotoxine spezifische antikoerper.
SE7604242L (sv) Forfarande for kvantitativ bestemning av en antigen substans och en diagnostisk sats
ATE16219T1 (de) Immunologisches latex-agglutinationsverfahren.
SE7709498L (sv) Forfaringssett vid framstellning av ett antiserum
NL167519C (nl) Werkwijze voor het bepalen volgens een radio-immuno- proef van de aanwezigheid van neisseria-gonorrhoeae- antilichamen in serum van de mens.
JPS6428560A (en) Immunometric measurement
FR2333243A2 (fr) Methode de preparation d'une solution d'anticorps
FR2277564A1 (fr) Procede de dosage immunologique utilisant un systeme heterologue d'anticorps ou d'antigenes
GB1316876A (en) Serological test devices and a process for the preparation
JPS55141452A (en) Synthetic polypeptide
EP0158291A3 (fr) Méthode de purification d'antigène carcino-embryonaire et méthode de production d'un anticorps monoclonal reagissant avec l'antigène carcino-embryonaire
JPH0694716A (ja) 免疫測定法
JPS5678598A (en) Method for measuring enzyme immunity by simultaneous determination of two components